Inventor
PLETTENBURG OLIVER
DE32 patents
⚠️ This page may combine multiple inventors who share the name “PLETTENBURG OLIVER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PLETTENBURG OLIVER
15 patentsUS8188117B2May 29, 2012
Piperidinyl-substituted isoquinolone derivatives
PLETTENBURG OLIVER9 citations83
US8278294B2Oct 2, 2012
Substituted isoquinoline and isoquinolinone derivatives as inhibitors of Rho-kinase
PLETTENBURG OLIVER11 citations82
US8742116B2Jun 3, 2014
Cycloalkylamine substituted isoquinolone derivatives
PLETTENBURG OLIVER4 citations71
US8609691B2Dec 17, 2013
Cyclohexylamin isoquinolone derivatives
PLETTENBURG OLIVER2 citations62
US8541449B2Sep 24, 2013
Substituted isoquinolines and isoquinolinones as Rho kinase inhibitors
PLETTENBURG OLIVER3 citations60
US8796458B2Aug 5, 2014
Cyclohexylamine isoquinolone derivatives
PLETTENBURG OLIVER1 citations51
US8399482B2Mar 19, 2013
6-substituted isoquinolines and isoquinolinones
PLETTENBURG OLIVER1 citations51
US8461144B2Jun 11, 2013
Substituted isoquinoline and isoquinolinone derivatives
PLETTENBURG OLIVER1 citations50
US8722671B2May 13, 2014
Isoquinoline derivatives
PLETTENBURG OLIVER0 citations48
US8501736B2Aug 6, 2013
Isoquinoline derivatives
PLETTENBURG OLIVER0 citations48
US8772492B2Jul 8, 2014
Substituted isoquinoline and isoquinolinone derivatives
PLETTENBURG OLIVER0 citations39
US8748614B2Jun 10, 2014
Substituted isoquinoline and isoquinolinone derivatives
PLETTENBURG OLIVER0 citations39
US8524737B2Sep 3, 2013
Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives
PLETTENBURG OLIVER0 citations39
US8710228B2Apr 29, 2014
Cycloalkylamine substituted isoquinoline derivatives
PLETTENBURG OLIVER0 citations37
US8710077B2Apr 29, 2014
Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives
PLETTENBURG OLIVER0 citations35
SANOFI AVENTIS DEUTSCHLAND
4 patentsUS7288528B2Oct 30, 2007
Aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
SANOFI AVENTIS DEUTSCHLAND31 citations92
US7101856B2Sep 5, 2006
Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
SANOFI AVENTIS DEUTSCHLAND29 citations92
US7666848B2Feb 23, 2010
Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
SANOFI AVENTIS DEUTSCHLAND2 citations62
US7820804B2Oct 26, 2010
Fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
SANOFI AVENTIS DEUTSCHLAND6 citations60
CALIFORNIA INST OF TECHN
3 patentsUS9070733B2Jun 30, 2015
Nanopillar field-effect and junction transistors with functionalized gate and base electrodes
CALIFORNIA INST OF TECHN15 citations91
US9966443B2May 8, 2018
Nanopillar field-effect and junction transistors with functionalized gate and base electrodes
CALIFORNIA INST OF TECHN0 citations51
US9960238B2May 1, 2018
Nanopillar field-effect and junction transistors with functionalized gate and base electrodes
CALIFORNIA INST OF TECHN0 citations51
SANOFI SA
3 patentsUS11090364B2Aug 17, 2021
Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein
SANOFI SA1 citations62
US8686150B2Apr 1, 2014
6-(4-hydroxy-phenyl)-3-alkyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
SANOFI SA3 citations57
US9133181B2Sep 15, 2015
Substituted 6-(4-hydroxy-phenyl)-1H-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors
SANOFI SA1 citations47